Source: Annual Congress 2012 - COPD comorbidities I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Tanni, A. Zamuner, K. Schelini, L. Coelho, L. Caram, S. Vale, R. Ferrari, I. Godoy, S. Paiva, I. Godoy (Botucatu, Brazil). Triglycerides are associated with five-year mortality in COPD patients. Eur Respir J 2012; 40: Suppl. 56, 522

Member's Comments

No comment yet.

Related content which might interest you: hsCRP is associated with 10-year mortality in COPD. Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020 Risk charts of five-year mortality in COPD patients Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Predictors of mortality in a well-characterised group of patients with COPD Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 Mortality of patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 631s Year: 2007 Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis. Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Predictors of mortality in COPD patients after hospitalization due to an exacerbation Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Anemia and mortality in COPD patients Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality Source: International Congress 2015 – COPD: interesting notes Year: 2015 Predictors of mortality in COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Predictors of mortality in COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 30-days mortality in patients admitted with COPD Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Exacerbations and mortality of COPD patients with cardiovascular disease in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Risk factors for mortality in patients with COPD exacerbation Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 No impact of statins on time to first COPD exacerbation or all-cause mortality Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Adherence to treatment strategies correlates with the annual rate of hospitalizations and 1-year mortality in patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 One-year mortality in COPD patients after severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004 Prevalence of comorbidity in patients with COPD and its effect on mortality Source: Annual Congress 2003 - Staging and outcome in COPD Year: 2003